AbbVie announced its full-year financial guidance for 2026
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
According to the guidelines, after taking into account the impact of the acquisition of IPR&D (In-Process Research and Development projects with already obtained intellectual property) and milestone expenses occurring in the first quarter of 2026, the company expects full-year adjusted diluted earnings per share to be between $13.96 and $14.16.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$78,299.57
+1.31%
Ethereum
ETH
$2,369.18
+2.60%
Tether USDt
USDT
$1
+0.03%
XRP
XRP
$1.43
+0.83%
BNB
BNB
$635.77
+1.14%
USDC
USDC
$1
+0.04%
Solana
SOL
$86.93
+1.48%
TRON
TRX
$0.3241
-0.05%
Dogecoin
DOGE
$0.09933
+1.73%
Hyperliquid
HYPE
$41.96
+1.88%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now